Search Results

Interim 30-Day Data Presented From FLASH Registry of Inari’s FlowTriever System

November 13, 2020—Inari Medical, Inc. announced that 30-day follow-up results of the first patients enrolled in the FLASH study were presented by National Principal Investigator Catalin Toma, MD, at the American Heart Association (AHA) Scientific Sessions 2020 held as a virtual meeting on November 13-17.

FLASH Registry Evaluates Inari Medical’s FlowTriever for Thrombectomy in PE Patients

October 19, 2020—Inari Medical, Inc. announced interim results from the first 230 patients enrolled in its FLASH study from a real-world pulmonary embolism (PE) population, including high- and intermediate-risk patients enrolled at 19 sites in the United States.

Inari Medical’s FlowTriever Evaluated in Interim Data From FLASH Registry of Pulmonary Embolism Patients

October 28, 2021—Inari Medical, Inc. announced positive acute and long-term interim results from the first 500 pulmonary embolism (PE) patients enrolled in FLASH, the FlowTriever Outcomes Registry.

FLASH Registry Evaluates Inari's FlowTriever System for Pulmonary Embolism

December 6, 2018—Inari Medical, Inc. announced the commencement of enrollment in the all-comers FLASH registry studying the safety and hemodynamics of the company's FlowTriever system for the treatment of pulmonary embolism (PE).

SPIRARE II Pivotal Trial of Jupiter’s Vertex Pulmonary Embolectomy System Completes Enrollment

February 5, 2026—Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the company’s Vertex pulmonary embolectomy system in patients with acute, intermediate-risk pulmonary embolism (PE).

Jupiter Endovascular Receives IDE Approval for SPIRARE II Pivotal Trial

September 10, 2024—Jupiter Endovascular, Inc., announced recently that the FDA has approved the company’s application for an investigational device exemption (IDE) for the SPIRARE II pivotal study in the United States.

Inari Medical Announces Publication of Results From the FLARE IDE Study

May 7, 2019—Inari Medical, Inc. announced that results from the 106-patient, prospective, multicenter FLARE investigational device exemption study of the company's FlowTriever mechanical pulmonary embolectomy device were published by Thomas Tu, MD, et al in Journal of the American College of Cardiology: Cardiovascular Interventions (2019;12:859–869).